Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million
Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support...
Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million
Financial Expert, Charmaine Tang, joins Gore Range Capital as Industry Advisor
Renowned Dermatologist - Dr. Matt Leavitt joins Gore Range Capital as an Executive Partner
Gore Range Capital Congratulates Dr. Seemal Desai, 2024 President of the AAD
Evommune Wins Gore Range Capital Skin Health Innovation Competition
Dr. Pimple Popper featured as Special Guest Judge for Skin Health Innovation Competition
Announcing Our Newest Team Member, Chidi Nwankpa, MD, MBA
AMWELL Enhances Virtual Care Platform with Two Acquisitions: SilverCloud Health and Conversa Health
The Silicon Review names Conversa as one of the 50 Fastest Growing Companies in the Year 2021
Gore Range Capital Adds Dr. Richard D. Granstein to Advisory Board for Skin Health Investments
Here’s Why This Southlake-Based VC Is Investing in the Future of Skin Health
Why this VC moved his firm to North Texas to launch its second fund (Video)